Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Murphy

Showing results (11-20 of 176) with videos related to

Pageof 18
Sort By:
Advances in Therapy|March 6, 2010
Abacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIVChad J Achenbach, Kimberly K Scarsi, Robert L Murphy
Future Virology|July 7, 2011
Atazanavir/ritonavir-based combination antiretroviral therapy for treatment of HIV-1 infection in adultsChad J Achenbach, Kristin M Darin, Robert L Murphy, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 16, 2002
The AIDS autopsy spleen: a comparison of the pre-anti-retroviral and highly active anti-retroviral therapy erasLeslie K Diaz, Robert L Murphy, John P Phair, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 21, 2005
Incidence of pancreatitis in HIV-1-infected individuals enrolled in 20 adult AIDS clinical trials group studies: lessons learnedRonald B Reisler, Robert L Murphy, Robert R Redfield, et al.
Archives of Gynecology and Obstetrics|March 16, 2010
Predictors of atypical squamous cell of undetermined significance cervical cytology with high-risk human papilloma virus genotypesJonah Musa, Babafemi Taiwo, Susan Goldsmith, et al.
AIDS (London, England)|June 19, 2012
The history of antiretroviral therapy and of its implementation in resource-limited areas of the worldStefano Vella, Bernard Schwartländer, Salif Papa Sow, et al.
Expert Opinion on Pharmacotherapy|December 14, 2011
Combination nucleoside/nucleotide reverse transcriptase inhibitors for treatment of HIV infectionMaxwell O Akanbi, Kimberly K Scarsi, Kimberly Scarci, et al.
Open Forum Infectious Diseases|December 20, 2021
Continued Low Rates of Hepatitis C Virus (HCV) Recurrence in HCV/HIV- and HCV-Infected Participants Who Achieved Sustained Virologic Response After Direct-Acting Antiviral Treatment: Final Results From the AIDS Clinical Trials Group A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)David L Wyles, Minhee Kang, Roy M Matining, et al.
Open Forum Infectious Diseases|April 3, 2023
Adverse Impact of HIV-1 on Long-term Outcomes Following HCV DAA Treatment: Final Results of ACTG A5320, the Viral Hepatitis C Infection Long-term Cohort Study (VHICS)David L Wyles, Minhee Kang, Roy M Matining, et al.
Open Forum Infectious Diseases|July 7, 2018
Similar Low Rates of HCV Recurrence in HCV/HIV- and HCV-Infected Participants who Achieved SVR After DAA Treatment: Interim Results From the ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)David L Wyles, Minhee Kang, Roy M Matining, et al.
Pageof 18

Showing results (11-20 of 176) with videos related to

Sort By:
Pageof 18
Advances in Therapy|March 6, 2010
Abacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIVChad J Achenbach, Kimberly K Scarsi, Robert L Murphy
Future Virology|July 7, 2011
Atazanavir/ritonavir-based combination antiretroviral therapy for treatment of HIV-1 infection in adultsChad J Achenbach, Kristin M Darin, Robert L Murphy, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 16, 2002
The AIDS autopsy spleen: a comparison of the pre-anti-retroviral and highly active anti-retroviral therapy erasLeslie K Diaz, Robert L Murphy, John P Phair, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 21, 2005
Incidence of pancreatitis in HIV-1-infected individuals enrolled in 20 adult AIDS clinical trials group studies: lessons learnedRonald B Reisler, Robert L Murphy, Robert R Redfield, et al.
Archives of Gynecology and Obstetrics|March 16, 2010
Predictors of atypical squamous cell of undetermined significance cervical cytology with high-risk human papilloma virus genotypesJonah Musa, Babafemi Taiwo, Susan Goldsmith, et al.
AIDS (London, England)|June 19, 2012
The history of antiretroviral therapy and of its implementation in resource-limited areas of the worldStefano Vella, Bernard Schwartländer, Salif Papa Sow, et al.
Expert Opinion on Pharmacotherapy|December 14, 2011
Combination nucleoside/nucleotide reverse transcriptase inhibitors for treatment of HIV infectionMaxwell O Akanbi, Kimberly K Scarsi, Kimberly Scarci, et al.
Open Forum Infectious Diseases|December 20, 2021
Continued Low Rates of Hepatitis C Virus (HCV) Recurrence in HCV/HIV- and HCV-Infected Participants Who Achieved Sustained Virologic Response After Direct-Acting Antiviral Treatment: Final Results From the AIDS Clinical Trials Group A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)David L Wyles, Minhee Kang, Roy M Matining, et al.
Open Forum Infectious Diseases|April 3, 2023
Adverse Impact of HIV-1 on Long-term Outcomes Following HCV DAA Treatment: Final Results of ACTG A5320, the Viral Hepatitis C Infection Long-term Cohort Study (VHICS)David L Wyles, Minhee Kang, Roy M Matining, et al.
Open Forum Infectious Diseases|July 7, 2018
Similar Low Rates of HCV Recurrence in HCV/HIV- and HCV-Infected Participants who Achieved SVR After DAA Treatment: Interim Results From the ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)David L Wyles, Minhee Kang, Roy M Matining, et al.
Pageof 18